SPDR S&P World ex-US ETF

Most Recent

  • uploads///Graph
    Company & Industry Overviews

    Teva Has a Targeted Strategy to Expand in Major Growth Markets

    In Russia, Teva Pharmaceutical has created a strong portfolio of about 300 products and has been extensively developing its research pipeline.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Teva’s Commercial Strategy May Be Successful across Europe

    Teva Pharmaceutical (TEVA) currently operates in three types of markets in the European Union.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    How Is Teva Aiming to Lead the Abuse-Deterrent Opioid Segment?

    Teva Pharmaceutical Industries (TEVA) expects Vantrela, an abuse-deterrent opioid, to be approved by the FDA in 2016.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.